Acquisition Announced

Bayer acquisition of Perfuse Therapeutics

US$300m consideration

Announced 6 May 2026

Advisers

Target
Perfuse Therapeutics
Acquirer
Bayer
Target based in
United States
Buyer based in
Germany
Sector
Biotech
Tags
Biotech, Ophthalmology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.